1. Home
  2. FRT vs BMRN Comparison

FRT vs BMRN Comparison

Compare FRT & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Federal Realty Investment Trust

FRT

Federal Realty Investment Trust

HOLD

Current Price

$115.52

Market Cap

9.6B

Sector

Real Estate

ML Signal

HOLD

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

HOLD

Current Price

$52.75

Market Cap

10.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRT
BMRN
Founded
1962
1996
Country
United States
United States
Employees
320
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
10.4B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
FRT
BMRN
Price
$115.52
$52.75
Analyst Decision
Buy
Buy
Analyst Count
13
18
Target Price
$112.08
$88.22
AVG Volume (30 Days)
716.9K
1.6M
Earning Date
05-01-2026
05-04-2026
Dividend Yield
4.09%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.54
Revenue
N/A
$1,313,646,000.00
Revenue This Year
$6.10
$15.02
Revenue Next Year
$4.64
$12.23
P/E Ratio
$22.54
$100.07
Revenue Growth
N/A
17.62
52 Week Low
$89.99
$50.76
52 Week High
$117.22
$66.28

Technical Indicators

Market Signals
Indicator
FRT
BMRN
Relative Strength Index (RSI) 66.27 41.02
Support Level $103.41 $52.06
Resistance Level N/A $56.52
Average True Range (ATR) 1.72 1.70
MACD 0.25 0.04
Stochastic Oscillator 77.47 6.12

Price Performance

Historical Comparison
FRT
BMRN

About FRT Federal Realty Investment Trust

Federal Realty Investment Trust is a shopping center-focused retail real estate investment trust that owns high-quality properties in eight of the largest metropolitan markets. Its portfolio includes an interest in 104 properties, which includes 28.8 million square feet of retail space and 2,700 multifamily units. Federal's retail portfolio includes grocery-anchored centers, superregional centers, power centers, and mixed-use urban centers. Federal Realty has focused on owning assets in highly desirable areas with significant growth, and as a result, the average population density and average median household income are higher for its portfolio than for any other retail REIT.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: